CN114223817A - Haematococcus pluvialis astaxanthin beverage - Google Patents
Haematococcus pluvialis astaxanthin beverage Download PDFInfo
- Publication number
- CN114223817A CN114223817A CN202010940271.0A CN202010940271A CN114223817A CN 114223817 A CN114223817 A CN 114223817A CN 202010940271 A CN202010940271 A CN 202010940271A CN 114223817 A CN114223817 A CN 114223817A
- Authority
- CN
- China
- Prior art keywords
- haematococcus pluvialis
- beverage
- astaxanthin
- proportion
- concentrated juice
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
- A23L2/02—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof containing fruit or vegetable juices
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
- A23L2/52—Adding ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
- A23L33/12—Fatty acids or derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Nutrition Science (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Mycology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
The invention discloses a haematococcus pluvialis astaxanthin beverage, which consists of the following components: purified water, red date concentrated juice, lemon concentrated juice, haematococcus pluvialis, citric acid, vitamin C and sucralose. The haematococcus pluvialis astaxanthin beverage has the advantages that the natural astaxanthin is added, so that the beverage has super oxidation resistance, has a protection effect on human body cells, can be used for treating the peroxidation damage of the cells of an organism, has a remarkable prevention and treatment effect on hypertension, hyperlipidemia, diabetes and complications thereof, various chronic organ inflammations, rheumatism bone diseases, gout, tumors and other chronic diseases, and has long-acting and lasting effects on resisting oxidation, removing wrinkles, whitening, resisting aging, improving the immunity of the organism and the like.
Description
Technical Field
The invention relates to the technical field of astaxanthin, in particular to haematococcus pluvialis astaxanthin beverage.
Background
Natural astaxanthin, a powerful antioxidant called anti-aging king, has 6000 times of the efficacy of vitamin C in its ability to scavenge free radicals; 1000 times of vitamin E; is 100 times of the efficacy of beta-carotene; is 20 times of the efficacy of selenium; 700 times of the efficacy of anthocyanin; 320 times of the efficacy of tea polyphenol; is 10 times of the efficacy of lycopene; 800 times of coenzyme Q10; 240 times of the effect of grape seed extract; 200 times the efficacy of carotol (lutein); is 3000 times of resveratrol.
The existing beverage has poor health preserving effect and has no excessive benefit to the health of human bodies, so that the haematococcus pluvialis astaxanthin beverage is provided.
Disclosure of Invention
The invention aims to provide a haematococcus pluvialis astaxanthin beverage to solve the problems in the background technology.
In order to achieve the purpose, the invention provides the following technical scheme: a haematococcus pluvialis astaxanthin beverage comprises the following components: purified water, red date concentrated juice, lemon concentrated juice, haematococcus pluvialis, citric acid, vitamin C and sucralose.
Preferably, the proportion of the purified water is 250 g.
Preferably, the proportion of the red date concentrated juice is 50 g.
Preferably, the proportion of the lemon concentrated juice is 50 g.
Preferably, the proportion of the haematococcus pluvialis is 0.5-3 g.
Preferably, the proportion of the citric acid is 0.5 g.
Preferably, the proportion of the vitamin C is 0.5 g.
Preferably, the proportion of the sucralose is 1 g.
Compared with the prior art, the invention has the beneficial effects that: the haematococcus pluvialis astaxanthin beverage has the super-strong inoxidizability of natural astaxanthin, has a protection effect on the whole body cells of a human body, can be used for treating the peroxidation damage of the cells of the body, has obvious prevention and treatment effects on hypertension, hyperlipidemia, diabetes and complications thereof, various chronic organ inflammations (oral ulcer, chronic gastritis, gastric ulcer, enteritis, duodenal ulcer, chronic nephritis and the like), rheumatism bone diseases, gout, tumors and other chronic diseases, has long-acting and lasting effects on resisting oxidation, wrinkle removal, whitening, aging, improving the immunity of the body and the like, has efficacies on strengthening the functions of a rabbit epidemic system, resisting cancer, protecting retina from ultraviolet radiation and photooxidation, resisting inflammation, preventing the oxidative damage of blood low-density lipoprotein (LDL) -cholesterol and the like, and develops astaxanthin-containing health care products. Strengthening immune system function, resisting cancer, protecting retina from ultraviolet radiation and photooxidation, resisting inflammation, and preventing oxidative damage of blood Low Density Lipoprotein (LDL) -cholesterol.
Detailed Description
The technical solutions in the embodiments of the present invention will be clearly and completely described below in conjunction with the embodiments of the present invention, and it is obvious that the described embodiments are only a part of the embodiments of the present invention, and not all of the embodiments. All other embodiments, which can be derived by a person skilled in the art from the embodiments given herein without making any creative effort, shall fall within the protection scope of the present invention.
The invention provides a technical scheme that: a haematococcus pluvialis astaxanthin beverage comprises the following components: the proportion of purified water, red date concentrated juice, lemon concentrated juice, haematococcus pluvialis, citric acid, vitamin C and sucralose purified water is 250g, the proportion of red date concentrated juice is 50g, the proportion of lemon concentrated juice is 50g, the proportion of haematococcus pluvialis is 0.5-3g, the proportion of citric acid is 0.5g, the proportion of vitamin C is 0.5g, the proportion of sucralose is 1g, the ultrastrong inoxidizability of astaxanthin is used for protecting the cells of the whole human body, and the astaxanthin can be used for treating the peroxidation injury of the cells of the body, hypertension, hyperlipidemia, diabetes and complications thereof and various chronic organ inflammations;
the added astaxanthin has ultraviolet resistance and radiation resistance; enhancing immunity; resisting oxidation, inflammation, aging and fatigue; enhancing organism metabolism, and relieving sports fatigue; eye and central nervous system protection; preventing cardiovascular diseases; inhibiting nephropathy, diabetes mellitus and complications thereof; preventing cancer, inhibiting tumor; free radicals are removed, and damaged cells of the whole body are repaired.
Although embodiments of the present invention have been shown and described, it will be appreciated by those skilled in the art that changes, modifications, substitutions and alterations can be made in these embodiments without departing from the principles and spirit of the invention, the scope of which is defined in the appended claims and their equivalents.
Claims (8)
1. The haematococcus pluvialis astaxanthin beverage is characterized by comprising the following components: purified water, red date concentrated juice, lemon concentrated juice, haematococcus pluvialis, citric acid, vitamin C and sucralose.
2. The haematococcus pluvialis astaxanthin beverage according to claim 1, wherein: the proportion of the purified water is 250 g.
3. The haematococcus pluvialis astaxanthin beverage according to claim 1, wherein: the proportion of the red date concentrated juice is 50 g.
4. The haematococcus pluvialis astaxanthin beverage according to claim 1, wherein: the proportion of the lemon concentrated juice is 50 g.
5. The haematococcus pluvialis astaxanthin beverage according to claim 1, wherein: the proportion of haematococcus pluvialis is 0.5-3 g.
6. The haematococcus pluvialis astaxanthin beverage according to claim 1, wherein: the proportion of the citric acid is 0.5 g.
7. The haematococcus pluvialis astaxanthin beverage according to claim 1, wherein: the proportion of the vitamin C is 0.5 g.
8. The haematococcus pluvialis astaxanthin beverage according to claim 1, wherein: the proportion of the sucralose is 1 g.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010940271.0A CN114223817A (en) | 2020-09-09 | 2020-09-09 | Haematococcus pluvialis astaxanthin beverage |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010940271.0A CN114223817A (en) | 2020-09-09 | 2020-09-09 | Haematococcus pluvialis astaxanthin beverage |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN114223817A true CN114223817A (en) | 2022-03-25 |
Family
ID=80742560
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202010940271.0A Pending CN114223817A (en) | 2020-09-09 | 2020-09-09 | Haematococcus pluvialis astaxanthin beverage |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN114223817A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN116649510A (en) * | 2023-06-15 | 2023-08-29 | 厦门市养真保健食品有限公司 | Antioxidant and anti-aging fruit and vegetable juice beverage and preparation method and application thereof |
| CN117562195A (en) * | 2023-12-07 | 2024-02-20 | 浙江索契壹营养科技有限公司 | Chinese and western compound beverage for whitening, removing freckles and resisting wrinkles, and preparation method and application thereof |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105795287A (en) * | 2016-03-24 | 2016-07-27 | 陕西思尔生物科技有限公司 | Nutrition-supplementing fermented beverage for different groups of people and preparation method thereof |
| CN105942091A (en) * | 2016-05-18 | 2016-09-21 | 李树森 | Haematococcus pluvialis drink |
| US20190254990A1 (en) * | 2016-06-08 | 2019-08-22 | Astareal Co., Ltd. | Food or beverage composition containing astaxanthin |
| CN111466502A (en) * | 2020-04-14 | 2020-07-31 | 攀枝花学院 | Astaxanthin anti-fatigue sports beverage and preparation method thereof |
| CN111480850A (en) * | 2020-05-19 | 2020-08-04 | 昆明白鸥微藻技术有限公司 | Haematococcus pluvialis and collagen protein beverage |
-
2020
- 2020-09-09 CN CN202010940271.0A patent/CN114223817A/en active Pending
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105795287A (en) * | 2016-03-24 | 2016-07-27 | 陕西思尔生物科技有限公司 | Nutrition-supplementing fermented beverage for different groups of people and preparation method thereof |
| CN105942091A (en) * | 2016-05-18 | 2016-09-21 | 李树森 | Haematococcus pluvialis drink |
| US20190254990A1 (en) * | 2016-06-08 | 2019-08-22 | Astareal Co., Ltd. | Food or beverage composition containing astaxanthin |
| CN111466502A (en) * | 2020-04-14 | 2020-07-31 | 攀枝花学院 | Astaxanthin anti-fatigue sports beverage and preparation method thereof |
| CN111480850A (en) * | 2020-05-19 | 2020-08-04 | 昆明白鸥微藻技术有限公司 | Haematococcus pluvialis and collagen protein beverage |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN116649510A (en) * | 2023-06-15 | 2023-08-29 | 厦门市养真保健食品有限公司 | Antioxidant and anti-aging fruit and vegetable juice beverage and preparation method and application thereof |
| CN117562195A (en) * | 2023-12-07 | 2024-02-20 | 浙江索契壹营养科技有限公司 | Chinese and western compound beverage for whitening, removing freckles and resisting wrinkles, and preparation method and application thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US6572899B1 (en) | Memory loss treatment formulation | |
| CN114223817A (en) | Haematococcus pluvialis astaxanthin beverage | |
| US9827208B2 (en) | Antioxidant dietary supplement compositions and methods for maintaining healthy skin | |
| Burke et al. | Momordica cochinchinensis, Rosa roxburghii, wolfberry, and sea buckthorn-highly nutritional fruits supported by tradition and science | |
| CN101496856A (en) | Proanthocyanidin chewing tablet | |
| KR101682394B1 (en) | Cosmetic composition comprising color food extracts | |
| Chauhan et al. | Potential role of phytochemicals of fruits and vegetables in human diet | |
| Bof et al. | Effect of freezing and processing technologies on the antioxidant capacity of fruit pulp and jelly | |
| CN108175723A (en) | With whitening and prevent the composition of skin aging and its application in cosmetics | |
| Machado et al. | Nutraceuticals for healthy skin aging | |
| CN102894435B (en) | Mulberry-medlar leaf beverage with function of asthenopia relieving | |
| WO2007142984A2 (en) | Nutritional formulations and associated methods | |
| CN103053731A (en) | Grape tea | |
| CN109793075A (en) | A kind of Cranberry fruit tea nutrient formulation | |
| CN102415445A (en) | Carambola beverage | |
| CN114745968A (en) | Diamond cherry mixture-a dietary supplement ingredient based on a mixture of biomass containing cherries, tart cherries or cherry blossom and natural antioxidants | |
| CN105105147A (en) | Nutrition and health care supplement rich in lutein and astaxanthin as well as preparation method | |
| Cheung et al. | Potential of Asian natural products for health in aging | |
| CN103622889B (en) | Radish sprout beauty facial mask powder and preparation method thereof | |
| CN101530379A (en) | Skin care product prepared by rosemary volatile oil, rosemary seed oil and fat-soluble component extracted by rosemary branch and leave | |
| CN104351876A (en) | Sweet tea drink with freckle-removing efficacy and preparation method thereof | |
| WO2024083949A1 (en) | Oral composition, a process for its manufacture and its use against skin aging | |
| KR102786547B1 (en) | Composition for diet containing garcinia and seaweed extract and method for preparing same | |
| Bose et al. | Comparative analysis of the of red seaweed polysaccharides on hypertension–associated biomarkers in cadmium chloride-induced Wistar rats | |
| US20220160810A1 (en) | Methods for continuous extraction and purification of a unique flavan-3-ol extract from immature whole grape clusters and compositions thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20220325 |